IP Verse

Novo Nordisk A/s opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Novo Nordisk A/s

Patent Number:
EP3056568
Title:
Methods For Controlling Blood Pharmacokinetics Of Antibodies
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jun 15, 2022
Patent Number:
EP3653223
Title:
Device For The Oral Delivery Of Therapeutic Compounds
Applicant:
RANI THERAPEUTICS, LLC
Opposition Date:
May 25, 2022
Patent Number:
EP1869065
Title:
A Method Of Weak Partitioning Chromatography
Applicant:
WYETH
Opposition Date:
Feb 5, 2021
Patent Number:
EP3461478
Title:
Swallowable Drug Delivery Device
Applicant:
RANI THERAPEUTICS, LLC
Opposition Date:
Jan 21, 2021
Patent Number:
EP2544668
Title:
Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery Device
Applicant:
INCUBE LABS, LLC
Opposition Date:
Apr 16, 2020
Patent Number:
EP2515992
Title:
Swallowable Drug Delivery Device And Methods Of Drug Delivery
Applicant:
INCUBE LABS, LLC
Opposition Date:
Jul 9, 2019
Patent Number:
EP2708559
Title:
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Dec 19, 2018
Patent Number:
EP2786657
Title:
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Nov 6, 2018

Latest patents of Novo Nordisk A/s opposed by its competitors

Patent:
EP3488857
Grant Date:
Oct 4, 2023
Title:
Compositions Of Glp-1 Peptides And Preparation Thereof
Oppositions:
5
Patent:
EP3542790
Grant Date:
Sep 13, 2023
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Oppositions:
7
Patent:
EP3746111
Grant Date:
Jul 19, 2023
Title:
Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant
Oppositions:
4
Patent:
EP3870213
Grant Date:
Jun 7, 2023
Title:
Stable Semaglutide Compositions And Uses Thereof
Oppositions:
1
Patent:
EP3634468
Grant Date:
Dec 14, 2022
Title:
Solid Compositions For Oral Administration
Oppositions:
1
Patent:
EP3448416
Grant Date:
Aug 10, 2022
Title:
Semaglutide In Cardiovascular Conditions
Oppositions:
8
Patent:
EP3423082
Grant Date:
Aug 4, 2021
Title:
Liraglutide In Cardiovascular Conditions
Oppositions:
5
Patent:
EP2863895
Grant Date:
Apr 14, 2021
Title:
Tablet Formulation Comprising A Peptide And A Delivery Agent
Oppositions:
7
Patent:
EP3137186
Grant Date:
Jan 27, 2021
Title:
Methods For The Purification Of Proteins Using Caprylic Acid
Oppositions:
2
Patent:
EP2866825
Grant Date:
Apr 8, 2020
Title:
Use Of Long-Acting Glp-1 Peptides
Oppositions:
3

Competitors of Novo Nordisk A/s

GENERICS (U.K.) LIMITED

GALENICUM HEALTH S.L.U.

HEXAL AG

Want to track Novo Nordisk A/s?

Feel free to send us a message here and we will get back to you